Clinical Trial Update: Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating oxaliplatin, fludarabine, cytarabine, and rituximab in Richter's syndrome and refractory chronic lymphocytic leukemia (CLL)/prolymp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Prolymphocytic Leukemia
• Richter Transformation

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Fludarabine (Fludarabine)
• OXALIPLATIN (Oxaliplatin)
• Rituximab (rituximab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2011-08-29